Early-Stage R33 Trials for Pharmacologic or Neuromodulatory Device Treatments for Mental Illness (Clinical Trial Required)
This NOFO funds single-phase, early-stage clinical trials testing pharmacologic agents with novel mechanisms or neuromodulatory devices to treat symptoms or functional domains in people with mental illness, including prodromal cases. Proposals must test the presumed mechanism of action and demonstrate dose-dependent neurophysiological, clinical, or behavioral effects. Studies may target pediat…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers